# Polygen Pharmaceuticals Inc. – FDA Inspection, Dec 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/polygen-pharmaceuticals-inc/db9a03de-763e-40f3-a107-b08d41abc5b9
Source feed: FDA_Inspections

> FDA inspection 1036340 of Polygen Pharmaceuticals Inc., December 18, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1036340
- Company Name: Polygen Pharmaceuticals Inc.
- Inspection Date: 2017-12-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 919209 - 2015-03-24](https://www.keypedia.com/records/fda_inspections/polygen-pharmaceuticals-inc/56b6c88a-1a10-44c3-b389-22d4a0415136)
- FDA Inspection 894579 - 2014-08-29

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)
- Issuing Officer

Company: https://www.keypedia.com/companies/polygen-pharmaceuticals-inc/d7df0d1f-787a-4629-b096-255e664d26ef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c